Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Aug 2026.
- Largest single sale: $4.9M (19,639 shares) of Jazz Pharmaceuticals plc on Aug 27, 2026. Filing
- Last sale before this period: Mar 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Aug 12, 2019 | Aug 31, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 27, 2026, Jazz Pharmaceuticals plc: sold 76,921 shares for $19.2M, under a disclosed plan; 57,500 shares acquired by exercising options. 1 filing: 1
- Jun 30, 2026, Jazz Pharmaceuticals plc: 3,764 shares withheld by the company for taxes. 1 filing: 1
- Mar 5, 2026, Jazz Pharmaceuticals plc: 6,209 shares withheld by the company for taxes. 1 filing: 1
- Feb 26, 2026, Jazz Pharmaceuticals plc: 14,822 shares granted. 1 filing: 1
- Jan 16, 2026, Jazz Pharmaceuticals plc: 11,699 shares awarded; 4,140 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.